Research News

Summaries of research findings that tell of a scientific need to "rethink psychiatry."

European Regulators Urge Open Drug Trial Data for All

0
In a paper published in PLoS Medicine, representatives of regulatory agencies in the U.K., France, and the Netherlands argue that clinical trial data should...

Self-Understanding is Key for Caregivers

0
Norwegian and Swedish researchers studied the experiences of 67 parents of children disabilities. They found that enhanced self-understanding and discussion of existential issues was...

Louisiana Court Rejects J&J’s Bid to Throw Out $258 million Risperdal Award

5
The state appeals court of Lake Charles, Louisiana found that "the trial court was not manifestly erroneous in casting (Johnson & Johnson owner) Janssen...

Perceived Social Status Impacts Early Psychosis

4
Writing in the British Journal of Clinical Psychology, London researchers find that perceptions of lower social rank and inferiority amongst 24 individuals with early...

Glaxo Claims Contrition and Changes in its Sales Practices

1
Following a record-setting spate of settlements, GlaxoSmithKline North America President Dierdre Connelly touts Glaxo's move away from a sales model that encourages the misbehavior...

Normal Anxiety vs. Mental Illness

0
Sharon Begley, author of "Train Your Mind, Change Your Brain," asks about the distinction between normal, healthy anxiety and mental illness and the implied...

Former Drug Reviewer Speaks Out About FDA Failures

1
TruthOut interviews a former drug reviewer for the Center For Drug Evaluation and Research at the FDA, who says the center "placed the nation...

Drug Company Suing FDA Over Right to Discuss Off-label Uses

3
A manufacturer of a prescription omega-3 fatty acid derivative wants the right to tell physicians about benefits of its drug which the FDA has not approved.

Department of Defense Apologizes for Antipsychotic-Related Deaths

2
The Army Times reports on the Department of Defense's crackdown on off-label antipsychotics in the context of research showing a strong link between antipsychotics,...

50% of All Clinical Trials Go Unpublished

0
Half of the 600 randomly selected trials listed on ClinicalTrials.gov, a registry of publicly and privately supported clinical trials, had their results published in...

Arkansas AG Petitions Supreme Court Decision Favoring J&J

5
Saying that the Arkansas supreme court had departed from 170 years of precedent by deciding in favor of Johnson & Johnson on grounds not...

Global Survey: Do Antidepressants Work?

1
The Guardian and its partners in Europe - Le Monde, El Pais, La Stampa, Gazeta Wyborcza and Suddeutsche Zeitung - are conducting a global...

Senate Amendment Filed to Fight Inappropriate Antipsychotics in Nursing Homes

5
Senators Chuck Grassley of Iowa, Herb Kohl of Wisconsin and Richard Blumenthal of Connecticut filed an amendment to the Food and Drug Administration Safety...

Europe Issues Policy on Access to Clinical Trial Data, Criticisms Continue

2
The European Medicines Agency has announced in a press release its final policies on the open publication of data from clinical trials. Ed Silverman...

Pa. Court Hears Arguments in Dismissed Risperdal Case

0
A lawyer for Pennsylvania urged seven justices of the Pa. Commonwealth Court yesterday to allow the state's case against Johnson & Johnson's subsidiary Janssen...

Pharma Execs Barred from Federal Programs

4
Three former executives from Purdue Pharma have been barred by a federal appeals court from doing business with federal healthcare programs such as Medicare...

Response to Placebo is On the Rise

1
Study subjects' responses to placebo have increased from an average two-point decline in symptom ratings in studies done from 1991 to 1998, to an...

Media “Suicide by Cop” Portrayals Add to Misunderstanding

0
A study in Suicide and Life-Threatening Behavior finds that representations of "Suicide by Cop" (SBC) in the media misrepresent the reality of people who...

Closing Arguments Begin in Arkansas Risperdal Trial

3
Arkansas is asking for a minimum of $1.2 billion in fines for the 250,000 Risperdal prescriptions issued under its medicaid program. Fletch Trammel, lawyer...

State Of Mind Series Highlights Changes To Vermont Mental Health System

0
Vermont Public Radio's series State of Mind will explore the ripples through Vermont's mental health system since Tropical Storm Irene washed away the State Hospital. In...

Crowdfunding Science

0
Scientific American explores a crowdfunded approach to researching methamphetamine addiction, suggesting the approach is adaptable to pursuing other questions that are challenged to find...

5,012 Englishwomen Poisoned Last Year by Benzos, 8,501 by SSRIs

2
Addiction Today reports "Attention on illicit drugs has deflected focus from the gigantic scale of harms by legal, prescribed drugs. We give you the...

Risperdal Plaintiffs Ask Judge to Unseal Clinical Studies Data

0
Attorneys representing about 300 lawsuits alleging that Risperdal causes enlargement of breast tissue in men have asked a Pennsylvania judge to unseal relevant clinical...

Policy and Staffing are Key to Reducing Seclusion Rates

0
Dutch researchers examined the belief among psychiatric ward staff that patient characteristics explained the different rates of seclusion observed between facilities. They conclude that...

Pharma Prosecutions Begin to Pay for Themselves

0
In what may prove to be a tipping point for prosecutions against pharmaceutical companies, states are beginning to see their "enforcement efforts pay for...